OncoSec Medical Inc. Appoints Dr. Soldano Ferrone To Scientific Advisory Board
6/25/2014 8:47:07 AM
OncoSec Medical Inc. (OTCQB:ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr. Soldano Ferrone, M.D., Ph.D., to the company’s Scientific Advisory Board. Dr. Ferrone is an internationally renowned expert in tumor immunology, and will contribute his considerable expertise to the company as it works to advance an expanding intratumoral immunotherapy pipeline.
Help employers find you! Check out all the jobs and post your resume.
comments powered by